Julian Michael Babarczy Reports No Securities Ownership in Alterity Therapeutics

This Form 3 filing reports that Julian Michael Babarczy, a director of Alterity Therapeutics Ltd (ATHE), has no securities ownership in the company as of April 10, 2026. The filing indicates that Babarczy serves as a director but does not hold any ownership position in the company's securities. The filing was submitted on April 10, 2026, and confirms that the reporting owner has zero securities owned. This is a standard ownership disclosure required for company directors and officers, even when they hold no securities. The company trades on the Australian Securities Exchange under the symbol ATH.ASX in addition to its U.S. listing.